Jill Christensen is an experienced clinical trial leader that enjoys making the complex simple. After executing phase III pharmaceutical trials for 2 years, Jill switched over to the device industry. For the next 10 years, Jill conducted phase I/II studies for Medtronic's Cardiac Rhythm Disease Management. Currently, Jill works for a Medical Research Organization called The Integra Group and conducts both preclinical and clinical studies for a wide range of medical device companies.